Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Differential expression proteomics of human colorectal cancer based on a syngeneic cellular model for the progression of adenoma to carcinoma.

Roth U, Razawi H, Hommer J, Engelmann K, Schwientek T, Müller S, Baldus SE, Patsos G, Corfield AP, Paraskeva C, Hanisch FG.

Proteomics. 2010 Jan;10(2):194-202. doi: 10.1002/pmic.200900614.

PMID:
19899082
2.

Proteomic analysis reveals novel proteins associated with progression and differentiation of colorectal carcinoma.

Gan Y, Chen D, Li X.

J Cancer Res Ther. 2014 Jan-Mar;10(1):89-96. doi: 10.4103/0973-1482.131396.

3.

[Differential proteomic analysis of human colorectal carcinoma cell lines SW620 and SW480 with different metastatic potentials].

Qu LJ, Ding YQ, Liang L.

Di Yi Jun Yi Da Xue Xue Bao. 2005 Oct;25(10):1211-5, 1220. Chinese.

4.

Identification of differential proteins in colorectal cancer cells treated with caffeic acid phenethyl ester.

He YJ, Li WL, Liu BH, Dong H, Mou ZR, Wu YZ.

World J Gastroenterol. 2014 Sep 7;20(33):11840-9. doi: 10.3748/wjg.v20.i33.11840.

5.

A reference map of a human pituitary adenoma proteome.

Zhan X, Desiderio DM.

Proteomics. 2003 May;3(5):699-713.

PMID:
12748949
6.

Identification of prohibitin as a potential biomarker for colorectal carcinoma based on proteomics technology.

Chen D, Chen F, Lu X, Yang X, Xu Z, Pan J, Huang Y, Lin H, Chi P.

Int J Oncol. 2010 Aug;37(2):355-65.

PMID:
20596663
7.

Identification of proteins of human colorectal carcinoma cell line SW480 by two-dimensional electrophoresis and MALDI-TOF mass spectrometry.

Zhang YT, Geng YP, Zhou L, Lai BC, Si LS, Wang YL.

World J Gastroenterol. 2005 Aug 14;11(30):4679-84.

8.

Suppression of human selenium-binding protein 1 is a late event in colorectal carcinogenesis and is associated with poor survival.

Kim H, Kang HJ, You KT, Kim SH, Lee KY, Kim TI, Kim C, Song SY, Kim HJ, Lee C, Kim H.

Proteomics. 2006 Jun;6(11):3466-76.

PMID:
16645984
9.

Proteome analysis of gastric cancer metastasis by two-dimensional gel electrophoresis and matrix assisted laser desorption/ionization-mass spectrometry for identification of metastasis-related proteins.

Chen J, Kähne T, Röcken C, Götze T, Yu J, Sung JJ, Chen M, Hu P, Malfertheiner P, Ebert MP.

J Proteome Res. 2004 Sep-Oct;3(5):1009-16.

PMID:
15473690
10.

Identification of distinctive protein expression patterns in colorectal adenoma.

F Lam F, Jankova L, Dent OF, Molloy MP, Kwun SY, Clarke C, Chapuis P, Robertson G, Beale P, Clarke S, Bokey EL, Chan C.

Proteomics Clin Appl. 2010 Jan;4(1):60-70. doi: 10.1002/prca.200900084. Epub 2009 Nov 3.

PMID:
21137016
11.

Proteome study of colorectal carcinogenesis.

Stulík J, Hernychová L, Porkertová S, Knízek J, Macela A, Bures J, Jandik P, Langridge JI, Jungblut PR.

Electrophoresis. 2001 Aug;22(14):3019-25.

PMID:
11565796
12.

Subnuclear proteomics in colorectal cancer: identification of proteins enriched in the nuclear matrix fraction and regulation in adenoma to carcinoma progression.

Albrethsen J, Knol JC, Piersma SR, Pham TV, de Wit M, Mongera S, Carvalho B, Verheul HM, Fijneman RJ, Meijer GA, Jimenez CR.

Mol Cell Proteomics. 2010 May;9(5):988-1005. doi: 10.1074/mcp.M900546-MCP200. Epub 2010 Jan 20.

13.

Cell surface proteomics identifies glucose transporter type 1 and prion protein as candidate biomarkers for colorectal adenoma-to-carcinoma progression.

de Wit M, Jimenez CR, Carvalho B, Belien JA, Delis-van Diemen PM, Mongera S, Piersma SR, Vikas M, Navani S, Pontén F, Meijer GA, Fijneman RJ.

Gut. 2012 Jun;61(6):855-64. doi: 10.1136/gutjnl-2011-300511. Epub 2011 Sep 2.

PMID:
21890811
14.
15.

[Analysis of differential proteins in laryngeal carcinoma cell line Hep-2 with transfection of LCRG1].

Zhang XP, Xiao ZQ, Chen ZC, Li C, Li JL, Yu YH, Ouyang YM, Feng XP, Zhang PF.

Ai Zheng. 2006 Jan;25(1):22-8. Chinese.

PMID:
16405744
16.

Proteomic analysis of differentially expressed proteins between metastatic and non-metastatic human colorectal carcinoma cell lines.

Ying-Tao Z, Yi-Ping G, Lu-Sheng S, Yi-Li W.

Eur J Gastroenterol Hepatol. 2005 Jul;17(7):725-32.

PMID:
15947549
17.

Proteomic expression analysis of colorectal cancer by two-dimensional differential gel electrophoresis.

Alfonso P, Núñez A, Madoz-Gurpide J, Lombardia L, Sánchez L, Casal JI.

Proteomics. 2005 Jul;5(10):2602-11.

PMID:
15924290
18.

Differential proteomic analysis of human colorectal carcinoma cell lines metastasis-associated proteins.

Zhao L, Liu L, Wang S, Zhang YF, Yu L, Ding YQ.

J Cancer Res Clin Oncol. 2007 Oct;133(10):771-82. Epub 2007 May 15.

PMID:
17503081
19.

Proteomic analysis of colorectal cancer reveals alterations in metabolic pathways: mechanism of tumorigenesis.

Bi X, Lin Q, Foo TW, Joshi S, You T, Shen HM, Ong CN, Cheah PY, Eu KW, Hew CL.

Mol Cell Proteomics. 2006 Jun;5(6):1119-30. Epub 2006 Mar 21.

20.

Proteomic analysis of primary esophageal squamous cell carcinoma reveals downregulation of a cell adhesion protein, periplakin.

Nishimori T, Tomonaga T, Matsushita K, Oh-Ishi M, Kodera Y, Maeda T, Nomura F, Matsubara H, Shimada H, Ochiai T.

Proteomics. 2006 Feb;6(3):1011-8.

PMID:
16400690

Supplemental Content

Support Center